Dr. Phan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-805-0505Fax+1 414-955-0231
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2000 - 2003
- Baylor College of MedicineResidency, Internal Medicine, 1997 - 2000
- University of California, Irvine, School of MedicineClass of 1997
- University of California, DavisBS, Biochemistry, 1986 - 1990
Certifications & Licensure
- TX State Medical License 2001 - 2025
- WI State Medical License 2024 - 2025
- GA State Medical License 2017 - 2020
- NM State Medical License 2016 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Cancer Institution Faculty Educator of the Year University of Texas M D Anderson Cancer Center, 2010
- Division of Cancer Medicine’s Leadership in Excellence Award University of Texas M D Anderson Cancer Center, 2008
- Division of Cancer Medicine’s Teaching Department of the Year Award University of Texas M D Anderson Cancer Center, 2007-2008
- Join now to see all
Clinical Trials
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
- Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- ASO Visual Abstract: Impact of Regional Metastasis on Survival for Patients with Non-functional Pancreatic Neuroendocrine Tumors: A Systematic Review.Callisia N Clarke, Erin Ward, Valencia Henry, Kaitlyn Nimmer, Alexandria Phan
Annals of Surgical Oncology. 2025-02-23 - 1 citationsImpact of Regional Metastasis on Survival for Patients with Nonfunctional Pancreatic Neuroendocrine Tumors: A Systematic Review.Callisia N Clarke, Erin Ward, Valencia Henry, Kaitlyn Nimmer, Alexandria Phan
Annals of Surgical Oncology. 2024-08-01 - 3 citationsTreatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors.Callisia N Clarke, Paul Cockrum, Thomas J R Beveridge, Michelle Jerry, Donna McMorrow
Journal of Health Economics and Outcomes Research. 2023-01-01
Books/Book Chapters
Abstracts/Posters
- Risk of anxiety/depression events in patients newly diagnosed with neuroendocrine tumorsC. Chen, G.P. Hess, Z. Liu, J.C. Yao, A.T. Phan, J.W. Hill, ASCO, 1/1/2011
- Risk of osteoporosis/osteopenia events in patients newly diagnosed with neuroendocrine tumorsJ.W. Hill, C. Chen, G.P. Hess, Z. Liu, J.C. Yao, A.T. Pha, ASCO, 1/1/2011
- Neuroendocrine tumor disease state and PROMIS health-related quality of life scoresCella D, Beaumont JL, Liu Z, Phan AT, Choi S, Yao JC, ASCO, 1/1/2010
- Join now to see all
Lectures
- Management of NET & Adrenal Cancers1/1/2012
- Management of Advanced Gastric Cancer1/1/2007
- Advances Management of Upper GI Cancers1/1/2006
- Join now to see all
Press Mentions
- Ipsen’s Somatuline CLARINET Phase III Study Published Online in NEJMJuly 17th, 2014
Professional Memberships
- Member
- Member
Other Languages
- Vietnamese, French, Spanish
External Links
- LinkedInhttps://www.linkedin.com/in/alexandria-phan-71531a59/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: